Paper7436690
Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
Thorén P and 4 others. Arch Gen Psychiatry, 1980. Cited by 427 papers, by iCite.
Cite this record
ConductScience Library. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Papers, record 7436690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7436690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clomipramine | Major topic |
| Obsessive-Compulsive Disorder | Major topic |
| Adult | |
| Depressive Disorder | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Nortriptyline | |
| Psychiatric Status Rating Scales |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 427 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39582056 | Fusing multiplex heterogeneous networks using graph attention-aware fusion networks. | Sci Rep | 2024 | https://conductscience.org/library/papers/39582056 | PubMed |
| 30370851 | Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time. | Curr Neuropharmacol | 2019 | https://conductscience.org/library/papers/30370851 | PubMed |
| 29871422 | Obsessive-compulsive disorder in children and adolescents. A review of the literature. | Eur Child Adolesc Psychiatry | 1994 | https://conductscience.org/library/papers/29871422 | PubMed |
| 29306047 | Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods. | Contemp Clin Trials | 2018 | https://conductscience.org/library/papers/29306047 | PubMed |
| 27419272 | Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. | World J Biol Psychiatry | 2017 | https://conductscience.org/library/papers/27419272 | PubMed |
| 27318812 | Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. | Lancet Psychiatry | 2016 | https://conductscience.org/library/papers/27318812 | PubMed |
| 24392262 | Neuropsychiatric and behavioral profiles of 2 adults with williams syndrome: response to antidepressant intake. | Prim Care Companion CNS Disord | 2013 | https://conductscience.org/library/papers/24392262 | PubMed |
| 22536500 | Affective spectrum disorders in an urban Swedish adult psychiatric unit: a descriptive study. | Depress Res Treat | 2012 | https://conductscience.org/library/papers/22536500 | PubMed |
| 22003299 | Current management of obsessive and phobic states. | Neuropsychiatr Dis Treat | 2011 | https://conductscience.org/library/papers/22003299 | PubMed |
| 21584063 | Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response. | Indian J Psychiatry | 1997 | https://conductscience.org/library/papers/21584063 | PubMed |
| 21289770 | Principles of antidepressant use. | Can Fam Physician | 1981 | https://conductscience.org/library/papers/21289770 | PubMed |
| 21229040 | Obsessive Compulsive Disorder: Improving prognosis through therapy and drug treatment. | Can Fam Physician | 1991 | https://conductscience.org/library/papers/21229040 | PubMed |
| 20623923 | Drug treatment of obsessive-compulsive disorder. | Dialogues Clin Neurosci | 2010 | https://conductscience.org/library/papers/20623923 | PubMed |
| 16699602 | The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. | J Psychiatry Neurosci | 2006 | https://conductscience.org/library/papers/16699602 | PubMed |
| 16228147 | Assessment of pediatric obsessive-compulsive disorder: a critical review of current methodology. | Child Psychiatry Hum Dev | 2005 | https://conductscience.org/library/papers/16228147 | PubMed |
| 15609068 | Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect. | Psychopharmacology (Berl) | 2005 | https://conductscience.org/library/papers/15609068 | PubMed |
| 15123164 | Paradigms for pharmacologic use as a treatment component in feline behavioral medicine. | J Feline Med Surg | 2004 | https://conductscience.org/library/papers/15123164 | PubMed |
| 12452254 | Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive compulsive disorder? | Eat Weight Disord | 2002 | https://conductscience.org/library/papers/12452254 | PubMed |
| 11140782 | Obsessive-complusive disorder: pharmacological treatment. | Eur Child Adolesc Psychiatry | 2000 | https://conductscience.org/library/papers/11140782 | PubMed |
| 9067123 | A risk-benefit assessment of buspirone in the treatment of anxiety disorders. | Drug Saf | 1997 | https://conductscience.org/library/papers/9067123 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7436690
GET https://conductscience.org/api/papers/v1/7436690/cited_by?page=2